Biotech & pharma
Researchers discover new signaling pathway linked to inflammatory disease
By By Scott LaFee | 17 Dec 2010
Warning lights mark shellfish that aren't safe to eat
By By Susan Brown | 16 Dec 2010
How the stem cell niche never dies
09 Dec 2010
Researchers report surprising AIDS-treatment benefits in Africa
By By Rex Graham | 02 Dec 2010
Genomic fault zones come and go
By By Daniel Kane | 01 Dec 2010
Trials use technology to help young adults achieve healthy weights
By By Doug Ramsey | 01 Dec 2010
Hormone therapy can make the brain ‘younger’
30 Nov 2010
Tests on postmenopausal women taking hormone therapy (HT) suggest that it can make their brains function more like those of younger women.
Winning the war against influenza
22 Nov 2010
Trained bacteria convert bio-wastes into plastic
20 Nov 2010
Cystic fibrosis gene typo is a double whammy
18 Nov 2010
Cholesterol-lowering statins boost bacteria-klling cells
By By Scott LaFee | 18 Nov 2010
Biologists identify genes that control toxic metal accumulation in plants
By By Kim McDonald | 17 Nov 2010
Research uncovers extensive natural recovery after spinal cord injury
By By Debra Kain | 17 Nov 2010
Bioengineers provide adult stem cells with simultaneous chemical, electrical and mechanical cues
By By Daniel Kane | 17 Nov 2010
India, UK sign MoU on joint crop research
12 Nov 2010
Latest articles
Featured articles
Artemis II and the economic outlook for lunar infrastructure
By Axel Miller | 01 Apr 2026
Artemis II will test deep-space systems and support future lunar missions, shaping the next phase of the global space economy.
Synthetic diplomacy: The $50 billion mirage and the new era of market-moving deepfakes
By Cygnus | 30 Mar 2026
Synthetic diplomacy shows how deepfakes could trigger market volatility, highlighting the growing need for verification in global financial systems.
AI war shifts gears: chips, drones reshape global power
By Cygnus | 27 Mar 2026
AI competition is shifting as chips, drones and supply chains reshape global power, impacting tech, defense and business strategies.
Trump’s Iran strike delay lifts markets, but risks remain elevated
By Axel Miller | 24 Mar 2026
Trump’s Iran strike delay eased market fears, sending oil lower and lifting Sensex. Risks remain as geopolitical tensions continue.
The rise of the ‘ghost executive’: how autonomous AI agents are entering the C-suite
By Cygnus | 17 Mar 2026
Autonomous AI agents are influencing business decisions and reshaping leadership structures as companies adopt agentic AI systems in 2026.
The sky is closing: The end of the global crossroads
By Axel Miller | 16 Mar 2026
Middle East airspace disruptions are forcing airlines to reroute global flights, raising costs and reshaping aviation networks in 2026.
Living in the “New Gulf”: how conflict is reshaping cities and infrastructure
By Cygnus | 16 Mar 2026
Gulf states are redesigning infrastructure, air defenses and aviation networks as regional tensions reshape urban resilience strategies.
The Petro-Tech Pivot: Why Your Next Phone Is Built on Shifting Sands
By Cygnus | 12 Mar 2026
Rising crude prices are reshaping electronics manufacturing as petrochemical costs drive pressure across the global tech supply chain.
Hardened compute: The rise of the data bunker
By Axel Miller | 11 Mar 2026
Explore how AI demand and geopolitical risk are driving investment in fortified data centers worldwide.


